Basilea Pharmaceutica AG (OTCMKTS:BPMUF) Sees Large Drop in Short Interest

Basilea Pharmaceutica AG (OTCMKTS:BPMUF) was the recipient of a large decrease in short interest during the month of November. As of November 15th, there was short interest totalling 26,700 shares, a decrease of 11.3% from the October 31st total of 30,100 shares. Based on an average daily trading volume, of 0 shares, the days-to-cover ratio is currently ∞ days.

Basilea Pharmaceutica Stock Performance

OTCMKTS BPMUF remained flat at $52.83 during mid-day trading on Tuesday. Basilea Pharmaceutica has a 12 month low of $38.60 and a 12 month high of $52.83. The business’s 50 day moving average price is $52.42 and its two-hundred day moving average price is $49.99.

Analyst Ratings Changes

Separately, HC Wainwright upgraded Basilea Pharmaceutica to a “strong-buy” rating in a report on Monday, September 23rd.

Basilea Pharmaceutica Company Profile

Basilea Pharmaceutica AG, a commercial-stage biopharmaceutical company, focuses on the development of products that address the medical needs in the therapeutic areas of oncology and anti-infectives. The company offers Cresemba, an intravenous and antifungal drug for the treatment of invasive aspergillosis and mucormycosis in the United States, and the European Union.